Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
06/13/2002 | WO2002030906B1 Anti-tumour compounds |
06/13/2002 | WO2002016362A3 Nitrogenous heterocyclic compounds |
06/13/2002 | WO2002016361A3 Nitrogenous heterocyclic compounds |
06/13/2002 | WO2002016360A3 Nitrogenous heterocyclic compounds |
06/13/2002 | WO2001098277A3 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
06/13/2002 | WO2001072721A3 Synergistic methods and compositions for treating cancer |
06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
06/13/2002 | US20020072521 For therapy of central nervous system disorders such as stress, anxiety, depression, cardiovascular disorders, and eating disorders |
06/13/2002 | US20020072500 3-(carboxy(hydroxy)alkylaminocarbonylmethylaminocarbonyl), 5-(tetrahydropyrimidin-2-yl-amino)phenol for example |
06/13/2002 | DE10061542A1 New alkanoylamino-pyrimidine derivatives used as antibacterial agents, especially for prevention and control of Staphylococcal infections |
06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
06/12/2002 | EP1212301A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
06/12/2002 | EP0916639B1 Liquid crystal compounds, liquid crystal compositions containing the compounds, and liquid crystal display devices made by using the compositions |
06/12/2002 | EP0889879B1 Butadiene derivatives and process for preparing thereof |
06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
06/12/2002 | EP0817773B1 Pyrimidine compounds |
06/12/2002 | EP0772603B1 Substituted pyrimidine compounds and their use |
06/12/2002 | CN1353706A Integrin receptor ligands |
06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
06/11/2002 | US6403600 Fungicides. |
06/11/2002 | US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
06/11/2002 | US6403580 Having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof. |
06/11/2002 | US6403534 Uracil compounds and use thereof |
06/11/2002 | US6403532 Herbicidal synergistic composition, and method of controlling weeds |
06/11/2002 | US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics |
06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
06/06/2002 | WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity |
06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
06/06/2002 | WO2001068614A3 5-substituted arylpyrimidines |
06/06/2002 | WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines |
06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
06/06/2002 | US20020068701 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
06/06/2002 | US20020066888 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices |
06/06/2002 | US20020066886 Alkenyloxy substituted bi or triaromatic compounds with atleast one benzene ring |
06/06/2002 | DE10060094A1 Preparation of 6-Amino-uracils used as stabilizer for halogenated polymers involves reacting N-(cyanoacetyl)-urea with base in matrix of plastics additives, plastics stabilizers and/or plastics |
06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
06/05/2002 | EP1211248A1 Process for the preparation of aminouraciles |
06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
06/05/2002 | EP1211246A1 Pyrimidine derivatives and herbicides containing the same |
06/05/2002 | EP1210349A2 PYRAZOLO 4,3-d]PYRIMIDINES |
06/05/2002 | EP1210347A1 Carbocyclic nucleosides and process for obtaining such |
06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
06/05/2002 | EP1210337A1 Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorous compounds |
06/05/2002 | EP1079917A4 Complexes of ultraviolet absorbers and quaternary ammonium compounds which are substantially free from unwanted salts |
06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
06/05/2002 | EP0891336B1 Substituted 1-methyl-3-benzyluracils |
06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
06/05/2002 | CN1352637A Process for preparing MKC-442 |
06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
06/04/2002 | US6399798 Method of preparing alkylated salicylamides |
06/04/2002 | US6399776 Processes and intermediates in the synthesis of 5-(3-exo-bicyclo[2.2.1]hept-2-yloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidine-2(1H)-one |
06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
06/04/2002 | US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
06/04/2002 | US6399603 Therapeutic heterocycles |
06/04/2002 | US6399602 Anticancer agents |
06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
06/04/2002 | US6399290 Silver halide imaging materials |
06/04/2002 | US6399223 Compound for use in organic EL device and organic EL device |
06/04/2002 | CA2364108A1 Acylamino cyclopropane derivatives |
05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
05/30/2002 | WO2002042262A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/30/2002 | WO2002041895A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
05/30/2002 | WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
05/30/2002 | US20020065271 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
05/30/2002 | CA2429570A1 Pyrimidine derivatives |
05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/29/2002 | EP1209152A1 Omega-amino-alpha-hydroxycarboxylic acid derivatives having integrin alpha v beta 3 antagonism |
05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
05/29/2002 | EP1208069A1 Process for catalyzing the oxidation of organic compounds |
05/29/2002 | EP1070076A4 Chiral separations of pyrimidines |
05/29/2002 | EP0873316B1 2-(o- pyrimidin-4-yl]methylenoxy)phenyl acetic acid derivatives and their use for controlling harmful fungi and animal pests |
05/29/2002 | CN1351635A Reactive dye compounds |
05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
05/29/2002 | CN1351598A Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
05/29/2002 | CN1351594A Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
05/29/2002 | CN1351593A Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
05/29/2002 | CN1351585A Method of producing methoxyimino acetic amide |
05/29/2002 | CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors |
05/29/2002 | CN1350787A Synergistic herbicidal composition and method |
05/29/2002 | CN1350786A Synergistic herbicidal composition and method |
05/29/2002 | CN1085666C 6-aryl pyrido (2,3-d) pyrimidines and naphthyridines for inhibiting protein tyro sine kinase medicated cellular proliferation |
05/29/2002 | CN1085663C Aromatic amino ethers as pain relieving agents |